Dandan Liang

Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3-TACC3 Fusion and Recurrent Glioblastoma.

Yongsheng Gao, Yong Wang, Henghui Zhang, 2020, The oncologist.

Biomarkers of Response to Combinational Use of PD-1 Blockade and Anti-angiogenesis: An Analysis from a Phase II Trial in Advanced Triple-negative Breast Cancer Patients

Qiang Liu, Quanren Wang, Jieqiong Liu, 2020 .

Chimeric antigen receptor T-cell therapy for T-ALL and AML

Dong Yang, Wenwen Wei, L. Zou, 2022, Frontiers in Oncology.

Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancers

Guanxiong Zhang, Jianming Xu, Henghui Zhang, 2021, Cancer Immunology, Immunotherapy.

Biomarkers of response to camrelizumab combined with apatinib: an analysis from a phase II trial in advanced triple-negative breast cancer patients

Qiang Liu, Quanren Wang, Jieqiong Liu, 2021, Breast Cancer Research and Treatment.

Utilization of circulating cell-free DNA profiling to guide first-line chemotherapy in advanced lung squamous cell carcinoma

Jianxing He, Guangfa Wang, Junling Li, 2021, Theranostics.

DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors

Henghui Zhang, Shukun Zhang, Jian Huang, 2021, Frontiers in Oncology.

Analysis of risk factors and gene mutation characteristics of different metastatic sites of lung cancer

Hua Zou, He Xiao, Bin Wang, 2021, Cancer medicine.

The CD68+ macrophages to CD8+ T-cell ratio is associated with clinical outcomes in hepatitis B virus (HBV)-related hepatocellular carcinoma.

H. Zhang, Henghui Zhang, Shupeng Liu, 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

HGF-Based CAR-T Cells Target Hepatocellular Carcinoma Cells That Express High Levels of c-Met

Q. Wei, Bin Sun, Wenwen Wei, 2023, Immunological investigations.